Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLDl 8, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, cancer of the gallbladder, and the metastases thereof.

Patents:
KR 20,100,021,573

Inventor(s): SAHIN UGUR [TR]; TUERECI OEZLEM [DE]; BRANDENBURG GUNDA [DE]; USENER DIRK [DE]

Type of Offer: Sale



« More Healthcare Patents
« More Medical Patents

---